Terbinafine Topical Creams /Solutions Suppliers & Bulk Manufacturers
Available Forms: Topical Creams /Solutions
Available Strengths: 1% cream, 1% solution
Reference Brands: Lamisil(US & EU)
Category:
Anti-fungal
Terbinafine inhibits fungal squalene epoxidase, disrupting ergosterol synthesis and damaging fungal cell membranes. It effectively treats dermatophyte skin infections with rapid relief, broad antifungal activity, and minimal side effects. Topical formulations provide targeted therapy for skin infections, ensuring effective, localized treatment with safety and convenience.
Terbinafine Topical Creams /Solutions is available in Topical Creams /Solutions
and strengths such as 1% cream, 1% solution.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Terbinafine Topical Creams /Solutions is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Terbinafine Topical Creams /Solutions can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Terbinafine topical creams and solutions are approved in the EU and US for treating dermatophyte skin infections. In the EU, brands like Lamisil are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and high manufacturing standards. In the US, FDA-approved terbinafine topical products, such as Lamisil, are backed by comprehensive clinical data and pharmacovigilance. Both regions require detailed dossiers for approval and continuous safety monitoring. For expert assistance with regulatory submissions, dossiers, and compliance, visit PharmaTradz. We support efficient market entry for terbinafine topical formulations, ensuring adherence to European and American standards for safe, effective antifungal therapy.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing